This week, a CRISPR trial for inherited blindness gets underway, a first-in-class retinitis pigmentosa treatment gains recognition from the FDA and an unusual retinitis pigmentosa case 50 years in the making. Source: AAO
This prospective trial evaluated the safety and efficacy of permethrin cream for the treatment of Demodex blepharitis. Source: AAO
Using data from AREDS and AREDS2, investigators examined the relationship between aspirin use and AMD progression. Source: AAO
The Academy is sharing important ophthalmology-specific information related to the new 2019-nCoV coronavirus, referred to as “2019-nCoV,” or simply the “Wuhan coronavirus.” Source: AAO
This study assessed the efficacy of recombinant human nerve growth factor therapy cenegermin (Oxervate) for neurotrophic keratopathy. Source: AAO
The authors of this prospective trial investigated whether Scheimpflug tomography could be used to predict the prognosis of Fuchs endothelial corneal dystrophy. Source: AAO
This week, a woman earns jail time for poisoning her husband with Visine, a self-moisturizing contact lens to combat dry eye and Mojo Vision reveals their plans for the world’s first smart contact lens. Source: AAO
This retrospective study characterized and classified central visual field loss that occurs in end-stage glaucoma. Source: AAO
This randomized trial assessed the efficacy of vibration in reducing injection site pain for patients undergoing cutaneous cancer removal. Source: AAO
People with thyroid eye disease finally have a nonsurgical option for improving proptosis, thanks to the FDA’s approval of Horizon Therapeutics’ teprotumumab (Tepezza). Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
